The therapeutic effect of exosomes in type 2 diabetes mellitus and its complications
Liu Y., Wang J., Sun Y., Chen Y.
Narrative Review on Type 2 Diabetes, Chronic Inflammation, published in Front Med (Lausanne) (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Front Med (Lausanne) (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41488105
- PMCID
- PMC12757354
- DOI
- 10.3389/fmed.2025.1735392
Abstract (original English)
Exosomes are a type of nanoscale extracellular vesicle secreted by cells, with a diameter of approximately 30-150 nm, which carry important biological molecules such as proteins, lipids, and RNA, functioning as messengers between cells and playing a central role in cell communication. Due to their involvement in various physiological and pathological processes and their low immunogenicity and good tissue penetration, exosomes have become a research hotspot for disease diagnostic markers and drug delivery carriers. Type 2 diabetes mellitus (T2DM) is a common chronic metabolic disorder characterized primarily by high blood sugar, whose core pathogenesis includes insulin resistance and the subsequent functional deficiency of pancreatic β-cells, which can lead to various serious complications over the long term. The review systematically elaborates on the key roles of exosomes from different cell sources in regulating T2DM and its complications, focusing on how these exosomes, through their specific microRNAs (miRNAs), proteins, and other active substances they carry, act on different key targets and thereby regulate core pathological processes such as insulin signaling pathways, inflammatory responses, cell apoptosis, fibrosis, and angiogenesis. Through the review of existing evidence, we aim to reveal the complex network of exosomes as intercellular messengers and provide a solid
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The Influence of GLP-1 Agonists on Human Mesenchymal Stem Cells: A Systematic Review
Systematic Review on Type 2 Diabetes, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep2 citations - Level ASystematic ReviewEurope PMC
Dedifferentiation of Mature Adipocytes and Their Future Potential for Regenerative Medicine Applications
Systematic Review on Type 2 Diabetes, Chronic Wound, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
Biomedicines - Level ASystematic ReviewEurope PMC
Consolidating Clinical Insights and Uncovering Novel Regulatory Mechanisms of Exosomal MicroRNAs in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease: A Systematic Review and Bioinformatics Analysis
Systematic Review on Type 2 Diabetes, Chronic Inflammation, published in Food Sci Nutr (2026) — summary generated from the PubMed abstract.
- 2026
Food Sci Nutr - Level AMeta-analysisEurope PMC
Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis
Meta-analysis on Type 2 Diabetes, Immune Modulation, published in World J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
World J Stem Cells1 citations - Level ASystematic ReviewPubMed
Systematic Review: Exosomes as Molecular Messengers in the Development of Obesity-Related Complications in Children.
Systematic Review on Type 2 Diabetes, published in Curr Issues Mol Biol (2025) — summary generated from the PubMed abstract.
- 2025
Curr Issues Mol Biol - Level AMeta-analysisEurope PMC
Thiamine as a putative natural modulator of PPARγ: exploring a nutrient-based approach for type 2 diabetes
Meta-analysis on Type 2 Diabetes, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol